EFG The 1‐month clinical worsening rate was 43.3% in the EFG group and 26.1% in the LPE group, although this difference did not reach statistical significance ( p = 0.412).
← all excerpts
Efgartigimod Versus Lymphoplasmapheresis as Preoperative Rapid Antibody-Clearing Therapies for Thymectomy in Generalized Myasthenia Gravis: Effectiveness, Safety and Cost Outcomes Compared to Conventional Preparation.
2
0.4120
0.4120
The sentences
For significant and marginally significant treatment effects, E ‐value sensitivity analyses revealed that at the point estimate level, surgery costs and perioperative costs (before reimbursement) showed treatment effect E ‐values exceeding those of the strongest known baseline variable associations (surgery cost: 2.19 vs. 2.04; perioperative costs (before reimbursement): 2.12 vs. 1.90).